EVAX

EVAX

USD

Evaxion Biotech A/S American Depositary Share

$5.600+0.030 (0.539%)

Prix en Temps Réel

Healthcare
Biotechnologie
Danemark

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$5.570

Haut

$6.010

Bas

$5.570

Volume

0.09M

Fondamentaux de l'Entreprise

Capitalisation Boursière

44.4M

Industrie

Biotechnologie

Pays

Denmark

Statistiques de Trading

Volume Moyen

1.59M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.2Actuel $5.600Haut $13.8

Actualités Connexes

GlobeNewswire

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for

Voir plus
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
GlobeNewswire

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a

Voir plus
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
GlobeNewswire

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report

Voir plus
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.